Need to file an Actos lawsuit? Contact Williams Kherkher today at 800-641-9810.

The FDA on Actos

Posted on November 28th, 2011 No Comments

The Food and Drug Administration has been investigating the use of the type 2 diabetes medication, Actos, since September 2010. In June 2011, the FDA announced that medications containing the ingredient pioglitazone( an active ingredient in Actos) must have a warning label on them about extended use of the medication and its link to bladder cancer.

Data from a 10-year ongoing study were looked into when it was determined that if a person used Actos for period of 24 months, there was an increased risk of bladder cancer associated with it. The FDA has warned physicians to be more careful when prescribing the medication, especially if the person has a history of bladder cancer in their family.

If you or a loved one has developed bladder cancer as a result of using Actos, you need experienced representation on your side. Contact the Actos lawsuit attorneys of Williams Kherkher in order to discuss your legal options.

Tagged , , | Leave a comment

Contact Williams Kherkher

By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.

home  |  about us  |  attorneys  |  actos  |  bladder cancer  |  faqs  |  articles  |  law resources  |  press release  |  contact us  |  blog  |  Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +